A point of view on hereditary thrombophilia and low-molecular-weight heparin incorporating the management in pregnancy and involving thyroidology
Rev Assoc Med Bras (1992)
.
2023 Sep 18;69(9):e20230735.
doi: 10.1590/1806-9282.20230735.
eCollection 2023.
Authors
Stefan Dugalić
1
,
Jovana Todorović
2
,
Maja Macura
1
,
Svetlana Vrzić Petronijević
1
,
Milos Petronijević
1
,
Miroslava Gojnić
1
,
Demet Sengul
3
,
Ilker Sengul
4
5
,
Anton Pelikán
6
7
,
Eduardo Carvalho de Arruda Veiga
8
Affiliations
1
University Clinical Center of Serbia, Clinic for Gynecology and Obstetrics - Belgrade, Serbia.
2
University of Belgrade, Faculty of Medicine, Institute of Social Medicine - Belgrade, Serbia.
3
Giresun University, Faculty of Medicine, Department of Pathology - Giresun, Turkey.
4
Giresun University, Faculty of Medicine, Division of Endocrine Surgery - Giresun, Turkey.
5
Giresun University, Faculty of Medicine, Department of General Surgery - Giresun, Turkey.
6
University of Ostrava, Faculty of Medicine, Department of General Surgery - Ostrava, Czech Republic.
7
Tomas Bata University in Zlin, Faculty of Humanities - Zlin, Czech Republic.
8
University of São Paulo, Faculty of Medicine of Ribeirão Preto, Department of Gynecology and Obstetrics - São Paulo (SP), Brazil.
PMID:
37729383
PMCID:
PMC10508948
DOI:
10.1590/1806-9282.20230735
No abstract available
Publication types
Editorial
MeSH terms
Female
Heparin, Low-Molecular-Weight* / therapeutic use
Humans
Pregnancy
Thrombophilia* / drug therapy
Substances
Heparin, Low-Molecular-Weight
Supplementary concepts
Thrombophilia, hereditary